Literature DB >> 2792310

Traveller's diarrhea among Austrian tourists to warm climate countries: II. Clinical features.

H Kollaritsch1.   

Abstract

The syndrome "Traveller's Diarrhea" (TD) is important for tourists travelling to warm-climate countries. In this study a worldwide survey on the clinical features of enteritis among 1,455 Austrian tourists is reported. The clinical parameters of TD show that this disease exhibits a very uniform clinical course which is not influenced by different regions with considerable differences in aetiology or by travel-associated parameters such as accommodation, travel style and individual dietary hygiene: TD starts mainly at the end of first week of the stay and the average duration of illness is 3.6 +/- 2.7 days. Watery and mucous stools were reported by 99% of patients with a frequency of 4 bowel movements per day, while bloody diarrhea occurred very rarely. However, 57.2% of patients suffered from abdominal cramps, less than one third of patients reported nausea and/or vomiting and fever accompanied the acute disease in 13%. Symptoms indicate that TD should not be considered a severe disease. The diarrheal illness will show the characteristics of an enteroinvasive disease only in rare cases. Treatment of TD is discussed: symptomatic or other non-antibiotic agents are preferable as antibiotics will only occasionally be necessary for treatment of an illness with a self-limiting character. For prophylaxis of TD, the preferable way to resolve the problem of TD in international travel, very few effective preparations are currently available, emphasizing the need for extensive research in this field.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2792310     DOI: 10.1007/bf00144838

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  23 in total

1.  Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university.

Authors:  H L DuPont; P Sullivan; L K Pickering; G Haynes; P B Ackerman
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

2.  Travelers' diarrhea in West Africa and Mexico: fecal transport systems and liquid bismuth subsalicylate for self-therapy.

Authors:  R Steffen; J J Mathewson; C D Ericsson; H L DuPont; A Helminger; T K Balm; K Wolff; F Witassek
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

3.  Intervention studies and the definition of dominant transmission routes.

Authors:  J Briscoe
Journal:  Am J Epidemiol       Date:  1984-09       Impact factor: 4.897

4.  Travelers' diarrhea. NIH Consensus Development Conference.

Authors: 
Journal:  JAMA       Date:  1985-05-10       Impact factor: 56.272

Review 5.  Pathogens that cause travelers' diarrhea in Latin America and Africa.

Authors:  R E Black
Journal:  Rev Infect Dis       Date:  1986 May-Jun

Review 6.  Antimicrobial therapy for infectious diarrhea.

Authors:  M M Levine
Journal:  Rev Infect Dis       Date:  1986 May-Jun

Review 7.  Etiology and epidemiology of travelers' diarrhea in Asia.

Authors:  D N Taylor; P Echeverria
Journal:  Rev Infect Dis       Date:  1986 May-Jun

Review 8.  Prevention of travelers' diarrhea by nonantibiotic drugs.

Authors:  R Steffen; R Heusser; H L DuPont
Journal:  Rev Infect Dis       Date:  1986 May-Jun

9.  Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea.

Authors:  H E Pichler; G Diridl; K Stickler; D Wolf
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

10.  Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth).

Authors:  H L DuPont; P Sullivan; D G Evans; L K Pickering; D J Evans; J J Vollet; C D Ericsson; P B Ackerman; W S Tjoa
Journal:  JAMA       Date:  1980-01-18       Impact factor: 56.272

View more
  1 in total

Review 1.  Probiotics in infectious diarrhoea in children: are they indicated?

Authors:  Y Vandenplas; S Salvatore; M Vieira; M Viera; T Devreker; B Hauser
Journal:  Eur J Pediatr       Date:  2007-07-05       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.